Acquired
Novo Nordisk (Ozempic)
David Rosenthal
The Novo CEO and Henry Brenham from the Nordisk side, they remain as co-CEOs for the next couple years. And Brenham notes that they are still a dwarf compared to the increasingly consolidated pharma market out there. But we are, quote, a specialized dwarf that will probably create a certain furor on the global stage.
0
💬
0
Comments
Log in to comment.
There are no comments yet.